“…In viral infections, the study of miRNAs in body fluids identified potential biomarkers for Ebola virus [ 172 ], HIV-1 [ 173 ], influenza A virus (IAV) [ 174 ], and rhinovirus [ 175 ] infections, which was further reviewed by [ 176 ]. Furthermore, the lncRNAs in biofluids have been reported as diagnostic markers for chronic hepatitis B virus (HBV) [ 177 ] and HBV-related cirrhosis [ 178 ], and as a prognostic marker for visual acuity in patients with acute retinal necrosis caused by herpes simplex virus type-1 (HSV-1) [ 179 ]. In addition, the circulating snoRNAs have been reported as potential prognostic markers for COVID-19 severity [ 180 ].…”